Asia Pacific, the cold plasma equipmentmarket, is anticipated to reach US$ 50.04 Mn in 2027 from US$ 14.20 Mn in 2019. The market is projected to grow with a CAGR of 17.1% from 2020-2027.
Thecold plasma equipment market is growing primarily due to the rising use of cold plasma in medical treatment, increasing hospital acquired infections (HAI) ), development of innovative methods for treatment of cancer through cold plasma and others in the Asia Pacific region that are boosting the market over the years. Restraining factors, such as adverse effects of cold plasma, and lack of reimbursementare likely to damage the growth of the market in the coming years. On the other hand, growing R&D expenditure for growth in the healthcare marketis expected to have a positive impact on the growth of the Asia Pacificcold plasma equipmentmarket in the coming years.
Cold plasma is also called as non-thermal plasma and used in wide range of applications in various industries including medical and biomedical industries. It is a powerful tool which is used to provide antimicrobial treatment for wounds and injuries. The cold plasma equipment technology offers non-thermal treatment of cancer, dentistry and others.
Cold plasma is proved very effective in the biomedicine. Cold plasma is used in many medical treatments such as, wound healing, cancer, dermatology, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, and inflammation, disinfection and scar treatment. Cold plasma's ability to kill bacteria, including the drug-resistant bacteria, to avoid further infection, helps in chronic wounds. This accelerates the process of wound healing and prevents further complications and the related discomforts. Although there are many other treatment methods for wound healing, it is expected that cold plasma therapy is one of the most effective ways. Plasma sources used in plasma medicine are typically "low temperature" plasma sources operated at atmospheric pressure. In this context, low temperature refers to temperatures similar to room temperature, usually slightly above. Increasing in cases of diabetes, wound and other inflammation, is growing the market
Diabetes affects many parts of the body, especially feet. Diabetic foot ulcers are sores that develop on the feet, and they can develop even from seemingly trivial injuries to the feet. Diabetic foot ulcers are a common cause of amputation due to diabetes. Across the globe, approximately every 30 seconds one leg is amputated because of diabetes. According to the report published by International Journal of Endocrinology, in 2017, approximately 15–25% of patients with diabetes are susceptible to foot ulcer during their lifetime. Due to rise in use of cold plasma, in various kind of treatment, it is likely to increase the cold plasma equipment market.
In 2019, the atmospheric cold plasma equipment accounted for the largest market share in Asia Pacificcold plasma equipmentmarket. Atmospheric cold plasmas, also called non-thermal plasmas, have attracted greater attention for its unique advantage in a new specialized field, plasma medicine. Atmospheric cold plasma gives the possibly highest plasma density. It is a unique, non-thermal glow discharge plasma operating system at atmospheric pressure. Atmospheric cold plasma, however, can also be used for the treatment of viable tissues and thus has become a focus of medical research over the past years. Other than therapeutic applications, CAP is also used for surface modification and biological decontamination. A different type of atmospheric cold plasma devices has been developed and tested for medical research purposes. In sequence, these can be divided into direct discharge (DBD: dielectric barrier discharge) and indirect discharge. Atmospheric pressure plasma jet) devices. The atmospheric cold plasma is have become a new innovative way for so many medical applications, such as disinfection, cancer treatment, root canal treatment, wound healing, and other medical applications. Theatmospheric cold plasma equipment segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development in healthcare.
In 2019, the wound healingsegment, held the most significant market share of the cold plasma equipmentmarket by the application. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the patients suffering from chronic, non-healing wounds. The segment is also anticipated to witness growth at a significant rate during the forecast period.
Some of the significant primary and secondary sources for cold plasma equipment included in the report are World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC).